WO2009047303A3 - Metabotropic glutamate receptor modulators for the treatment of pervasive developmental disorder - Google Patents
Metabotropic glutamate receptor modulators for the treatment of pervasive developmental disorder Download PDFInfo
- Publication number
- WO2009047303A3 WO2009047303A3 PCT/EP2008/063553 EP2008063553W WO2009047303A3 WO 2009047303 A3 WO2009047303 A3 WO 2009047303A3 EP 2008063553 W EP2008063553 W EP 2008063553W WO 2009047303 A3 WO2009047303 A3 WO 2009047303A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- pervasive developmental
- developmental disorder
- receptor modulators
- glutamate receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention concerns the use an mGluR modulator, e.g. an mGluR5 modulator, for the treatment, prevention or delay of progression of a pervasive developmental disorder. The invention further concerns the use of an mGluR modulator for the treatment, prevention or delay of progression of a disorder is selected from Fragile X syndrome and fragile X- associated tremor/ataxia syndrome (FXTAS).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97949107P | 2007-10-12 | 2007-10-12 | |
US60/979,491 | 2007-10-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009047303A2 WO2009047303A2 (en) | 2009-04-16 |
WO2009047303A3 true WO2009047303A3 (en) | 2009-08-27 |
Family
ID=40349986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2008/063553 WO2009047303A2 (en) | 2007-10-12 | 2008-10-09 | Metabotropic glutamate receptor modulators for the treatment of pervasive developmental disorder |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009047303A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8853392B2 (en) | 2007-06-03 | 2014-10-07 | Vanderbilt University | Benzamide mGluR5 positive allosteric modulators and methods of making and using same |
US8034806B2 (en) | 2007-11-02 | 2011-10-11 | Vanderbilt University | Bicyclic mGluR5 positive allosteric modulators and methods of making and using same |
WO2012084873A1 (en) * | 2010-12-20 | 2012-06-28 | Novartis Ag | 4- (hetero) aryl - ethynyl - octahydro - indole - 1 - carboxylic acid esters |
CN106187838B (en) * | 2016-07-13 | 2018-05-01 | 广东东阳光药业有限公司 | Aryl alkynes compound and its preparation method and application |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030100539A1 (en) * | 2001-04-02 | 2003-05-29 | Bear Mark F. | Methods of treating neurological disorders with group I mGluR antagonists |
WO2006094639A1 (en) * | 2005-03-04 | 2006-09-14 | F.Hoffmann-La Roche Ag | Pyridine-2-carboxamide derivatives as mglur5 antagonists |
WO2006114262A1 (en) * | 2005-04-25 | 2006-11-02 | Novartis Ag | Acetylene derivatives |
WO2006114260A1 (en) * | 2005-04-25 | 2006-11-02 | Novartis Ag | Phenylacetylene derivatives having mglur5 receptor affinity |
WO2007021575A2 (en) * | 2005-08-15 | 2007-02-22 | Astrazeneca Ab | Acetylenic piperazines as metabotropic glutamate receptor antagonists |
WO2007071358A1 (en) * | 2005-12-20 | 2007-06-28 | Novartis Ag | Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
-
2008
- 2008-10-09 WO PCT/EP2008/063553 patent/WO2009047303A2/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030100539A1 (en) * | 2001-04-02 | 2003-05-29 | Bear Mark F. | Methods of treating neurological disorders with group I mGluR antagonists |
WO2006094639A1 (en) * | 2005-03-04 | 2006-09-14 | F.Hoffmann-La Roche Ag | Pyridine-2-carboxamide derivatives as mglur5 antagonists |
WO2006114262A1 (en) * | 2005-04-25 | 2006-11-02 | Novartis Ag | Acetylene derivatives |
WO2006114260A1 (en) * | 2005-04-25 | 2006-11-02 | Novartis Ag | Phenylacetylene derivatives having mglur5 receptor affinity |
WO2007021575A2 (en) * | 2005-08-15 | 2007-02-22 | Astrazeneca Ab | Acetylenic piperazines as metabotropic glutamate receptor antagonists |
WO2007071358A1 (en) * | 2005-12-20 | 2007-06-28 | Novartis Ag | Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
Non-Patent Citations (3)
Title |
---|
BEERS M H ET AL: "Pervasive developmental disorders spectrum", THE MERCK MANUAL OF DIAGNOSIS AND THERAPY, WHITEHOUSE STATION, N.J. : MERCK RESEARCH LABORATORIES, vol. 18Eds, 1 January 2006 (2006-01-01), pages 2487, XP002516054, ISBN: 978-0-911910-18-6 * |
DÖLEN GÜL ET AL: "Courting a cure for fragile X.", NEURON 3 MAR 2005, vol. 45, no. 5, 3 March 2005 (2005-03-03), pages 642 - 644, XP002516059, ISSN: 0896-6273 * |
MCBRIDE SEAN M J ET AL: "Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome.", NEURON 3 MAR 2005, vol. 45, no. 5, 3 March 2005 (2005-03-03), pages 753 - 764, XP002516058, ISSN: 0896-6273 * |
Also Published As
Publication number | Publication date |
---|---|
WO2009047303A2 (en) | 2009-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008014008A3 (en) | Compositions and methods for modulating angiogenesis | |
WO2009047296A3 (en) | Metabotropic glutamate receptor modulators for the treatment op parkinson's disease | |
EP3861130A4 (en) | Engineered genetic modulators | |
AU2007213489A8 (en) | Optical modulator | |
WO2009064920A3 (en) | Compounds and methods for modulating protein expression | |
WO2006060662A3 (en) | Methods and systems for determining a display light source adjustment | |
EP2094640A4 (en) | Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar). | |
EP2174360A4 (en) | Electroactive polymer transducers for sensory feedback applications | |
WO2008031550A3 (en) | Nicotinic acid derivatives as modulators of metabotropic glutanate receptors | |
WO2009144495A3 (en) | Hydrophobic coating composition | |
WO2007092823A3 (en) | Sialagogue coatings for interproximal devices | |
WO2007081991A3 (en) | Novel conjugated materials featuring proquinoidal units | |
WO2007145875A3 (en) | Data coding | |
AU2008276512A8 (en) | Thiadiazole modulators of PKB | |
WO2008045507A3 (en) | Substituted tetracycline compounds for treatment of bacillus anthracis infections | |
WO2020122707A8 (en) | Hydrogel for in-vivo directional release of medication | |
BRPI0717313A2 (en) | REVERED DISCRETE CO-SENO DYNAMIC TRANSFORM BAND SIGNALING. | |
WO2007117687A3 (en) | Implants for the treatment of dopamine associated states | |
WO2009047303A3 (en) | Metabotropic glutamate receptor modulators for the treatment of pervasive developmental disorder | |
TW200736226A (en) | Novel histidine derivatives | |
EP4161844A4 (en) | Securable clip | |
WO2007132355A3 (en) | Compositions and methods for inhibiting viral adhesion | |
EP3983054A4 (en) | Micro-electro-mechanical-system structures and applications thereof | |
FR2893213B1 (en) | ANTI-VIBRATION PROTECTION DEVICES FOR MICROPHONE. | |
ECSP088314A (en) | HEXAHIDRO-CICLOHEPTAPIRAZOL CANNABINOID MODULATORS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08837741 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08837741 Country of ref document: EP Kind code of ref document: A2 |